Dr. Sanjay Pujari
Founder, Director & Chief Consultant, Institute of Infectious Diseases, Pune
Qualifications: MBBS, MD (Medicine), FIDSA
Experience: Over 30 years in HIV care, infectious diseases and antiretroviral therapy
Last Updated: May 2026
Prescription-Only Medicine
Inbec Tablet is a Schedule H prescription-only antiretroviral medicine. It must be taken only under the supervision of a qualified HIV specialist or registered medical practitioner. Do not start, stop, or change the dose of Inbec without medical guidance, as inappropriate use may lead to drug resistance, treatment failure, or serious adverse effects.
Medical Disclaimer
The information on this page about Inbec Tablet — Dolutegravir 50 mg + Abacavir 600 mg + Lamivudine 300 mg is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Inbec Tablet is a prescription-only antiretroviral medicine and must be taken only under the supervision of a qualified HIV specialist. Do not self-medicate, change the dose, skip doses, or stop treatment without medical advice. Because Abacavir can cause a serious hypersensitivity reaction, an HLA-B*5701 test is recommended before starting therapy.
Always inform your doctor about your medical history and any medicines or supplements you take. Inbec Tablet does not cure HIV/AIDS and should be used with regular viral load, CD4, liver, and kidney monitoring.
Medically reviewed by qualified clinicians at TAAL+ Healthcare. Last reviewed: May 2026.